GYRE THERAPEUTICS, INC. (GYRE)

(10% Negative) GYRE THERAPEUTICS, INC. (GYRE) Announces Delay in included Trials for discovery Due to Geopolitical Situation, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment